“Bupropion: Off-label treatment for cocaine and methamphetamine addiction” (Pearls, Current Psychiatry, July 2010, p. 52) was a well-written, succinct article addressing a pharmacologic treatment in a difficult population. Bupropion has been utilized to target cravings associated with cocaine and methamphetamine addiction with mixed success.1 Hopefully the cocaine vaccine mentioned in the article will be approved, which will provide clinicians with another agent for treating dual diagnosis patients.
Timothy R. Berigan, DDS, MD
Contract Psychiatrist
Behavioral Health Services
Fort Huachuca, AZ